New publication provides overview of the STOPCAP M1 programme
Tierney JF, Vale CL, Parelukar WR, Rydzewska L, Halabi S. Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate Cancer. European Urology Focus. 2019;5(2):137-43.
This paper describes how we are reviewing results and data from advanced prostate cancer trials in new and different ways to find out quickly which treatments are best and for which men. It also describes how we will identify measures of prognosis and prostate cancer control that can be used to improve the design and shorten the duration of new trials.
This paper is part of a special issue, edited by Professor Chris Sweeney, concentrating on ways to decrease deaths from prostate cancer.